glp-1 pill news today The FDA approved a new from Eli Lilly on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication Type 2 Diabetes: AstraZeneca's New

Hydrophobic molecules, such as anticancer agents, lipid-soluble vitamins, and small molecules, are integrated into the lipid bilayer, improving solubility and enabling targeted delivery to tissues or cells

Pharmacists like Pharmacist Jamie emphasize that consistency is key

Building payer- and employer-facing solutions that align incentives

CONFIDENTIAL 8 23

Of the total body weight lost with tirzepatide, around three quarters was fat mass and about a quarter was lean mass, a split that was almost identical to the placebo group, who lost a similar amount of weight through diet and lifestyle changes alone rather than medication